Product Code: VMR11215637
Value Market Research deeply researched the Global Ocular Drug Delivery System Market to foresee a significant growth in the industry over the upcoming years. The global ocular drug delivery system market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.
The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global ocular drug delivery system market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this ocular drug delivery system market.
The next sections of the ocular drug delivery system market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.
Countries Covered in the report are as below:
North America - United States, Canada, and Mexico
Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC
Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America
Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa
Market Segmentation in the report is as below-
By Technology
Topical
Iontophoresis (Ocular Insert(Erodible and Non-Erodible), and Intraocular Implants(Biodegradable and Non-Biodegradable)
In Situ Gel & Punctal Plugs
Others
By Formulation Type
Liposomes & Nanoparticles
Solution
Emulsion
Suspension
Ointment
By Disease Type
Glaucoma
Diabetic Retinopathy
Dry Eye Syndrome
Macular Degeneration
Cataract
Diabetic Macular Edema
Others
By End Users
Hospitals
Ophthalmic Clinics
Ambulatory Surgical Centers
Homecare Settings
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . OCULAR DRUG DELIVERY SYSTEM - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 By Technology
- 3.7.2 By Formulation Type
- 3.7.3 By Disease Type
- 3.7.4 By End Users
- 3.7.5 By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
- 5.1. Impact Analysis of Covid-19 Outbreak
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
- 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
- 5.3. Market: Pre V/S Post COVID-19
- 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
- 5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY TECHNOLOGY
- 6.1 Overview by Technology
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Technology
- 6.4 Topical Market by Regions
- 6.5 Iontophoresis Market by Regions
- 6.6 Ocular Insert Market by Regions
- 6.7 Intraocular Implants Market by Regions
- 6.8 In Situ Gel & Punctal Plugs Market by Regions
- 6.9 Others Market by Regions
7 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY FORMULATION TYPE
- 7.1 Overview by Formulation Type
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Formulation Type
- 7.4 Liposomes & Nanoparticles Market by Regions
- 7.5 Solution Market by Regions
- 7.6 Emulsion Market by Regions
- 7.7 Suspension Market by Regions
- 7.8 Ointment Market by Regions
8 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY DISEASE TYPE
- 8.1 Overview by Disease Type
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Disease Type
- 8.4 Glaucoma Market by Regions
- 8.5 Diabetic Retinopathy Market by Regions
- 8.6 Dry Eye Syndrome Market by Regions
- 8.7 Macular Degeneration Market by Regions
- 8.8 Cataract Market by Regions
- 8.9 Diabetic Macular Edema Market by Regions
- 8.10. Others Market by Regions
9 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY END USERS
- 9.1 Overview by End Users
- 9.2 Historical and Forecast Data
- 9.3 Analysis by End Users
- 9.4 Hospitals Market by Regions
- 9.5 Ophthalmic Clinics Market by Regions
- 9.6 Ambulatory Surgical Centers Market by Regions
- 9.7 Homecare Settings Market by Regions
10 . GLOBAL OCULAR DRUG DELIVERY SYSTEM MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America
- 10.3.1. Overview, Historic and Forecast Data
- 10.3.2. North America By Segment
- 10.3.3. North America By Country
- 10.3.4. United State
- 10.3.5. Canada
- 10.3.6. Mexico
- 10.4. Europe
- 10.4.1. Overview, Historic and Forecast Data
- 10.4.2. Europe by Segment
- 10.4.3. Europe by Country
- 10.4.4. United Kingdom
- 10.4.5. France
- 10.4.6. Germany
- 10.4.7. Italy
- 10.4.8. Russia
- 10.4.9. Rest Of Europe
- 10.5. Asia Pacific
- 10.5.1. Overview, Historic and Forecast Data
- 10.5.2. Asia Pacific by Segment
- 10.5.3. Asia Pacific by Country
- 10.5.4. China
- 10.5.5. India
- 10.5.6. Japan
- 10.5.7. South Korea
- 10.5.8. Australia
- 10.5.9. Rest Of Asia Pacific
- 10.6. Latin America
- 10.6.1. Overview, Historic and Forecast Data
- 10.6.2. Latin America by Segment
- 10.6.3. Latin America by Country
- 10.6.4. Brazil
- 10.6.5. Argentina
- 10.6.6. Peru
- 10.6.7. Chile
- 10.6.8. Rest of Latin America
- 10.7. Middle East & Africa
- 10.7.1. Overview, Historic and Forecast Data
- 10.7.2. Middle East & Africa by Segment
- 10.7.3. Middle East & Africa by Country
- 10.7.4. Saudi Arabia
- 10.7.5. UAE
- 10.7.6. Israel
- 10.7.7. South Africa
- 10.7.8. Rest Of Middle East And Africa
11 . COMPETITIVE LANDSCAPE OF THE OCULAR DRUG DELIVERY SYSTEM COMPANIES
- 11.1. Ocular Drug Delivery System Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12 . COMPANY PROFILES OF OCULAR DRUG DELIVERY SYSTEM INDUSTRY
- 12.1. Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. Taiwan Liposome Company, Ltd.
- 12.3.1. Company Overview
- 12.3.2. Financials
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. Valeant Pharmaceuticals International, Inc.
- 12.4.1. Company Overview
- 12.4.2. Financials
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Ocular Therapeutix, Inc.
- 12.5.1. Company Overview
- 12.5.2. Financials
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. Graybug Vision Inc.
- 12.6.1. Company Overview
- 12.6.2. Financials
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. Clearside Biomedical, Inc.
- 12.7.1. Company Overview
- 12.7.2. Financials
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. EyeGate Pharma
- 12.8.1. Company Overview
- 12.8.2. Financials
- 12.8.3. Products
- 12.8.4. Recent Developments
- 12.9. Envisia Therapeutics
- 12.9.1. Company Overview
- 12.9.2. Financials
- 12.9.3. Products
- 12.9.4. Recent Developments
- 12.10. Alimera Sciences
- 12.10.1. Company Overview
- 12.10.2. Financials
- 12.10.3. Products
- 12.10.4. Recent Developments
- 12.11. Allergan Plc
- 12.11.1. Company Overview
- 12.11.2. Financials
- 12.11.3. Products
- 12.11.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies